FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

765 letters match. Newest first.

  1. DongBang Cosmetics Co., Ltd.

    DongBang Cosmetics of Incheon shipped a hand sanitizer labeled 62% alcohol that tested at 55%, and it was refused at the U.S. border.

    High risk
  2. Dominant Nutrition LLC formerly 8 Weeks Out Labs

    FDA warned Dominant Nutrition that LipogenX is adulterated and website claims make three products unapproved drugs.

    High risk
  3. New Green Nutrition, Inc.

    FDA warned New Green Nutrition that its diabetes products were unapproved new drugs and one contained prescription glyburide sold without a prescription.

    High risk
  4. Organa International Corp.

    FDA warned Organa International that it sold colloidal minerals, tea, and silver gel as unapproved drugs using disease claims on its website.

    High risk
  5. The Camel Milk Co. LLC dba Camel Culture

    FDA warned The Camel Milk Co. over camel milk products marketed as drugs to treat COVID-19, autism, and other conditions.

    High risk
  6. Lauren R. Klein, MD, M.S.

    FDA cited Dr. Lauren R. Klein for running two emergency department drug studies without required investigational new drug applications.

    High risk
  7. Jon B. Cole, MD

    FDA warns Dr. Jon B. Cole he ran two pre-hospital drug studies without required INDs, adding risks for pregnant women, children, and intoxicated patients.

    High risk
  8. Notarika, S.A. de C.V.

    Notarika’s Greenfrog hand sanitizer was refused at the U.S. border after FDA found methanol instead of ethanol.

    High risk
  9. GuangZhou YouXing Cosmetic Co., Ltd

    FDA found Guangzhou YouXing's V&W hand sanitizer labeled 75% ethanol contained only 35%, and refused its import as adulterated and unapproved.

    High risk
  10. RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.

    FDA says RAAS Nutritionals ran human drug studies without required IND applications, despite claiming products were dietary supplements.

    High risk
  11. Limpo Quimicos, SA de CV

    Limpo Quimicos' hand sanitizers were refused at the U.S. border after FDA found methanol substitution and low ethanol.

    High risk
  12. Healthy Foods & Nutrition Lab de Mexico S.A. de C.V.

    Healthy Foods & Nutrition Lab de Mexico shipped hand sanitizer labeled 70% alcohol that tested at 13%, and lacked drug approval.

    High risk
  13. Ardil Comercial S.R.L.

    FDA found Ardil Comercial's Limar hand sanitizer contained less isopropyl alcohol and undeclared ethanol and was packaged like a water bottle.

    High risk
  14. ICA Health, LLC/Future Formulations, LLC

    ICA Health sells five Dr. Wilson supplements with website claims that make them unapproved new drugs, FDA says.

    Medium
  15. Strategia Project Management, Inc.

    FDA warned Strategia Project Management that its microSURE Hand Sanitizer is an unapproved, misbranded drug marketed with COVID-19 claims.

    High risk
  16. Supplement Science Corp. d/b/a Condemned Labz

    FDA warned Condemned Labz that five supplement products were unapproved new drugs and misbranded, and two were adulterated.

    High risk
  17. Holographic Health, Inc.

    FDA says Holographic Health marketed 14 products as unapproved new drugs through disease claims on its website.

    High risk
  18. Blue Poppy Enterprises Inc

    Blue Poppy Enterprises sold herbal products with disease-treatment claims as unapproved new drugs, FDA says.

    High risk
  19. Laboratorio Pharma International SRL

    FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.

    High risk
  20. Nanomateriales Químicos Avanzados, S.A. de C.V.

    FDA found Mexican maker Nanomateriales' ZANILAST hand sanitizer labeled 65% ethanol contained 1-propanol, with quality and labeling violations.

    High risk
  21. Furley Bioextracts SDN BHD

    FDA warns Furley Bioextracts over manufacturing failures and unapproved PainFix Relief Gel for the U.S. market.

    High risk
  22. Fibromyalgia Treatment Group - FTG, LLC

    FDA warned Fibromyalgia Treatment Group that its Fibrolief, Nerve Renew and other supplements are unapproved new drugs sold with disease-treatment claims.

    High risk
  23. McDaniel Water, LLC

    FDA told McDaniel Water its Black Indian Salve is an unapproved new drug because it is a corrosive topical product sold with disease-treatment claims.

    High risk
  24. New York Nutrition Company / American Metabolix

    FDA says New York Nutrition/American Metabolix sold supplements with unapproved drug claims and unsafe additives Hordenine HCl and Higenamine HCl.

    High risk
  25. Brilliant Enterprises LLC

    FDA warned Brilliant Enterprises that its mushroom products are unapproved new drugs because website and social media claims say they treat diseases.

    Medium
  26. Pharmaganics LLC

    FDA and FTC warn Pharmaganics over diabetes supplement claims that make unapproved, misbranded drugs.

    High risk
  27. Phytag Labs

    FDA and FTC warn Phytag Labs that its GLUCOTYPE2 supplement is an unapproved drug and misbranded due to diabetes treatment claims.

    Medium
  28. Nuturna International LLC

    Nuturna International marketed 'Diabetic Support Formula' with diabetes-treatment claims, making it an unapproved drug and misbranded.

    High risk
  29. Metamune Inc

    FDA and FTC warn Metamune over DiabetesSupport supplement claims to treat diabetes without approval.

    High risk
  30. Live Good Inc.

    Live Good Inc. sold Berry Gen Sugar Control supplements as a diabetes treatment without FDA approval, making it an unapproved, misbranded drug.

    High risk
  31. Radhanite, LLC d/b/a Curalife Ltd

    FDA and FTC say Curalife markets CuraLin supplement with unapproved diabetes-treatment claims.

    High risk
  32. Aceva, LLC

    Aceva, LLC marketed Sugar Balance supplement with unapproved diabetes and blood sugar drug claims, FDA says.

    High risk
  33. Ar-Rahman Pharm LLC

    FDA and FTC cite Ar-Rahman Pharm for Diabetes Support sold with unapproved diabetes-treatment claims.

    High risk
  34. Lysulin, Inc.

    Lysulin, Inc. marketed diabetes and weight-loss supplements as unapproved drugs and misbranded products.

    High risk
  35. Holistic Healer & Wellness Center, Inc.

    FDA and FTC warned Holistic Healer & Wellness Center that Diabalance Diabetes Supplement claims make it an unapproved new drug.

    High risk
  36. Kaleido Biosciences, Inc.

    Kaleido Biosciences ran COVID-19 clinical trials of KB109 without required IND, FDA says.

    High risk
  37. Genesis Nutrition Ultra Slim dba Genesis Ultra Slim

    Genesis Nutrition Ultra Slim sells Genesis Ultra Slim Gold, a weight-loss product that contains undeclared sibutramine and phenolphthalein.

    High risk
  38. 247rxpill.in

    FDA warned website 247rxpill.in for selling unapproved opioid and benzodiazepine drugs to U.S. consumers.

    High risk
  39. PowerAll Pharma

    FDA warned PowerAll Pharma for selling unapproved, misbranded opioid and benzodiazepine drugs online without prescriptions.

    High risk
  40. AnazaoHealth Corporation

    AnazaoHealth Corporation compounded drugs without meeting 503B conditions, including inadequate adverse event reporting.

    Medium
  41. Pharmaceutical Care Solutions dba Pharmacy Solutions

    FDA warns Pharmaceutical Care Solutions dba Pharmacy Solutions over compounded drugs made with ineligible bulk substances and lacking FDA approval.

    Medium
  42. Je Dois Lavoir LLC

    Je Dois Lavoir sells 365 Skinny High Intensity weight-loss drug containing undeclared sibutramine without FDA approval.

    High risk
  43. TeaTaze, LLC

    TeaTaze marketed eight teas with claims they treat diseases, including COVID-19, making them unapproved new drugs, FDA says.

    High risk
  44. Mahita, LLC dba PushMyCart

    FDA and FTC warn Mahita/PushMyCart over unapproved Ayurvedic/homeopathic COVID-19 treatment claims.

    High risk
  45. Tropicosmeticos SA de CV

    FDA found Tropicosmeticos SA de CV’s Britz hand sanitizer labeled 70% ethanol contained 0% ethanol and >50% methanol.

    High risk
  46. Maitland Labs of Central Florida

    FDA warns Maitland Labs of Central Florida over sterile compounded drugs with manufacturing quality failures, mislabeling, and unapproved new drug violations.

    High risk
  47. 1st Phorm LLC

    FDA warned 1st Phorm that its heart supplements were unapproved drugs and some supplements contained unsafe hordenine.

    High risk
  48. Secret of the Islands

    FDA warned Secret of the Islands that its salt scrub products are unapproved and misbranded drugs because of COVID-19 claims.

    High risk
  49. BBC Group Limited

    FDA cites BBC Group Limited for data integrity, lab, equipment failures and unapproved, misbranded hand sanitizers.

    High risk
  50. Chill6

    FDA told drink maker Chill6 its amino acid beverage is an unapproved new drug sold for anxiety and contains an unsafe additive.

    High risk